Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 40 | ESEBEC2016 | Next issue

ESE Basic Endocrinology Course on Endocrine and Neuroendocrine Cancer 2016

ESE Basic Course on Endocrine and Neuroendocrine Cancer 2016

Molecular Targeted Therapy in Medullary and Well-Differentiated Thyroid Carcinoma

ea0040l4 | Molecular Targeted Therapy in Medullary and Well-Differentiated Thyroid Carcinoma | ESEBEC2016

Molecular targeted therapy in medullary and well-differentiated thyroid carcinoma

Leite Valeriano

Differentiated thyroid cancer (DTC) of papillary (PTC) and follicular (FTC) types with invasive loco-regional or metastatic disease, poorly differentiated (PDTC) and anaplastic thyroid cancers (ATC), as well as the C-cell derived medullary thyroid cancers (MTC), represent the major cause of mortality amongst thyroid cancer patients. Because such patients are resistant to standard therapy, they may be excellent candidates for innovative adjuvant approaches such as molecular tar...

ea0040lb4 | Molecular Targeted Therapy in Medullary and Well-Differentiated Thyroid Carcinoma | ESEBEC2016

L4 – Biography

Valeriano Alberto Pais Horta Leite, MD, PhD was born in Lisbon in 1958. He completed his MD from the Faculty of Medicine of Lisbon in 1982 and Fellowship in Endocrinology 1991, Portuguese Institute of Oncology, Lisbon. In 1996, he was awarded the PhD degree by the Faculty of Medical Sciences, Lisbon.He is currently the Head of the Department Endocrinology, Portuguese Institute of Oncology, Lisbo...